Yale Researchers Find First Cases of New UK Coronavirus Variant in Connecticut
The variant cases were rapidly identified through a strong collaborative network at Yale to increase surveillance for the B.1.1.7 variant. The nasal swabs were tested by the Yale Pathology Lab and sequenced by the Yale School of Public Health.Source: YaleNews
National Women’s Hockey League Partners with Yale on COVID-19 Testing
The PCR viral RNA testing method — known as SalivaDirect — was developed by researchers at the Yale School of Public Health (YSPH). It was granted an emergency use authorization by the U.S. Food and Drug Administration after researchers performed clinical validation in collaboration with YSPH, Yale New Haven Hospital, and Yale Pathology Labs (YPL).Source: YaleNews
Vaccine Distribution in Burdened Communities Begins with Building Trust
While Black, Latinx, and Indigenous Americans are dying from COVID-19 at nearly three times the rate of white Americans, Dr. Marcella Nunez-Smith, an associate professor of internal medicine, public health, and management at Yale, worries that many people in these communities will be reluctant to receive the vaccines.Source: YaleNews
Yale Study Leads to FDA Approval of Drug to Treat Non-small Cell Lung Cancer
Based on results of a clinical trial led by Yale Cancer Center researchers, the U.S. Food and Drug Administration has approved osimertinib for the treatment of adults with early-stage, non-small cell lung cancer (NSCLC) with EGFR gene mutations, which occurs in about 10 percent of patients.
Black, Hispanic Children Bear Disproportionate Burden of COVID-19
Scientists from Yale and other pediatric centers found that three out of four children hospitalized with severe cases of COVID-19 were Black or Hispanic (23.3% Black and 51% Hispanic). In comparison, only 38% of adults aged 65 or over who were hospitalized were from a minority group (27% Black and 11% Hispanic), according to U.S. COVID data.Source: YaleNews
Rapid Response Fund Supports Researchers During Pandemic
In response to the devastating public health threat presented by COVID-19, the Yale School of Public Health has created a Rapid Response Fund. The fund provides immediate financial support to world-class researchers working on the pandemic’s front lines.
Success of COVID-19 Vaccination Program Depends on its Implementation
Factors related to manufacturing, distribution, public acceptance, and the severity of the pandemic will contribute more to the success of a potential COVID-19 vaccination program than the efficacy of the vaccine itself, finds a new study conducted by the Yale School of Public Health.Source: YaleNews
Biden Taps Three Experts with Yale Ties to Lead COVID-19 Advisory Board
President-elect Joe Biden has named three public health experts with close Yale ties to lead his transition team’s new COVID-19 advisory board, including Dr. Marcella Nunez-Smith, an authority on the pandemic’s disproportionate effect on communities of color.Source: Yale News
New COVID-19 Related Genes – Helpful and Harmful – Found in Massive Screen
Researchers at Yale University and the Broad Institute of MIT and Harvard screened hundreds of millions of cells exposed to the COVID-19 and MERS viruses and identified dozens of genes that both enable the viruses to replicate in cells and also those that seem to slam the door on the virus.
The Pathoanatomy of Posterolateral Corner Ligamentous Disruption in Multiligament Knee Injuries Is Predictive of Peroneal Nerve Injury
A team of Yale researchers closely analyzed where the specific zone of ligamentous injury occurred in a consecutive group of patients who sustained a highly uncommon knee injury where more than one major knee ligament is damaged.
New Insights on Genetic Risks for Cigarette Smoking
Scientists have long understood that genes play an important role in a person’s smoking behavior, and a new genome-wide association study by Yale and U.S. Department of Veterans Affairs (VA) researchers is helping to explain why some people start to smoke, while others are able to quit.